Pierre Laurent‐Puig

Research interests

Publications

• The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

  ESMO Open · 2023 · https://doi.org/10.1016/j.esmoop.2023.101567

• Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer

  Immunity · 2022 · https://doi.org/10.1016/j.immuni.2022.02.001

• Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.06.022

• Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features

  Gastroenterology · 2018 · https://doi.org/10.1053/j.gastro.2018.08.033

• Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)

  Clinical Cancer Research · 2017 · https://doi.org/10.1158/1078-0432.ccr-16-3155

• ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

  Annals of Oncology · 2016 · https://doi.org/10.1093/annonc/mdw235

• Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression

  Genome biology · 2016 · https://doi.org/10.1186/s13059-016-1070-5

• Prognostic Value ofBRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer

  JNCI Journal of the National Cancer Institute · 2016 · https://doi.org/10.1093/jnci/djw272

• The consensus molecular subtypes of colorectal cancer

  Nature Medicine · 2015 · https://doi.org/10.1038/nm.3967

• Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1

  Science · 2015 · https://doi.org/10.1126/science.aad0779

• Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

  The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70227-x

• Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.51.1857

• MicroRNA Related Polymorphisms and Breast Cancer Risk

  PLoS ONE · 2014 · https://doi.org/10.1371/journal.pone.0109973

• Large-scale genotyping identifies 41 new loci associated with breast cancer risk

  Nature Genetics · 2013 · https://doi.org/10.1038/ng.2563

• Genome-wide association studies identify four ER negative–specific breast cancer risk loci

  Nature Genetics · 2013 · https://doi.org/10.1038/ng.2561

• Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers

  The American Journal of Human Genetics · 2013 · https://doi.org/10.1016/j.ajhg.2013.01.002

• Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

  The Lancet Oncology · 2010 · https://doi.org/10.1016/s1470-2045(10)70130-3

• Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer

  Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2008.21.6796

• KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.12.5906

• Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC

  Hepatology · 2006 · https://doi.org/10.1002/hep.21068

• KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer

  Cancer Research · 2006 · https://doi.org/10.1158/0008-5472.can-06-0191

• Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

  Nature · 2001 · https://doi.org/10.1038/35079107

Current projects

No projects listed.